New-onset Type 1 Diabetes
2 clinical trials · Condition
◉ Watch New-onset Type 1 Diabetes
| Record | Firm | Date |
|---|---|---|
| A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline. (NCT04899271) | Dompé Farmaceutici S.p.A | 2020-12-14 |
| Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes (NCT02005848) | Kamada, Ltd. | 2014-04-01 |
Track New-onset Type 1 Diabetes automatically
Every clearance here is in the API, with alerts when new ones post.